A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy.
- Van Der Walt, Anneke (Primary Chief Investigator (PCI))
- Macdonnell, Richard (Chief Investigator (CI))
Project: Research